Previously submitted to: JMIR Aging (no longer under consideration since Aug 13, 2025)
Date Submitted: Apr 7, 2025
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Reimagining Dementia Screening: A Stakeholder-Informed Perspective on Innovation Opportunities
ABSTRACT
The recent advent of disease-modifying treatments for Alzheimer's disease (AD) demands a transformation in our approach to cognitive screening. Drawing from 123 stakeholder interviews conducted through the NSF I-Corps program, we examine the limitations of current screening practices and explore emerging opportunities for innovation. Our analysis reveals systemic challenges in current practice, including time constraints in primary care, learning effects in long-term care settings, and widespread staffing shortages across the care continuum. We identify several promising pathways for innovation, including AI-powered speech analysis for rapid screening and monitoring, differential diagnosis tools, and automated care planning solutions. The convergence of new treatments, technological capabilities, and pressing clinical needs creates an unprecedented opportunity to reimagine dementia screening. This viewpoint synthesizes insights from frontline healthcare providers and presents a vision for next-generation screening approaches that could significantly improve early detection and continuous monitoring of cognitive decline across care settings.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.